(2026) -
Chronological (626 items)
(All links open in new tab)
| May 1, 2026 |
Federal healthcare coverage for CBD is here. Hemp product standards are still needed.
The Centers for Medicare & Medicaid Services’ (CMMS) offer of limited coverage for certain hemp-derived CBD products represents a significant shift in how the U.S. healthcare system views cannabinoids. For patients, particularly those managing chronic pain or complex conditions, it signals a step toward broader access to alternative therapeutic options that an estimated 40 million Americans are already using. |
|---|---|
| May 1, 2026 |
The War on Europe’s Legal Hemp Industry
In April 2025, the Italian government used emergency constitutional powers to bypass parliament and reclassify non-intoxicating hemp as a narcotic, regardless of THC content, following multiple failed attempts to decimate the industry. When this law was put into effect in June of the same year, following no parliamentary debate and no transition period, a sector worth hundreds of millions of euros a year for the Italian economy, employing around 15,000 people directly, was gutted overnight, despite warnings that over 3,000 businesses would close. |
| May 1, 2026 |
Don’t toss cannabis leaves: Scientists found rare compounds with medical potential
Cannabis just revealed a hidden chemical treasure—rare compounds scientists never knew were there. Date: May 1, 2026 Source:Stellenbosch University Summary: Scientists have uncovered a surprising new layer of complexity in Cannabis, identifying dozens of previously unknown compounds—including the first-ever evidence of rare molecules called flavoalkaloids in its leaves. These compounds, prized for their potential health benefits, were hidden among a rich mix of plant chemicals that vary dramatically even between just a few strains. |
| Apr 30, 2026 |
They Said Weed Would Destroy America. They Were Wrong. They’re Still Cashing In.
n investigation into the infrastructure, incentives, and revenue streams behind prohibition advocacy — using professional writer Alex Berenson’s career as a case study in how misinformation survives evidence. |
| Apr 30, 2026 |
Marijuana Sales Record Major Spike on 4/20
Cannabis retailers across the U.S. recorded a notable surge in sales on April 20 (4/20) this year, with particularly strong gains in states that have recently approved legal use. Data released by online ordering company Jane Technologies shows that total sales on April 20 climbed by 46.9% compared to the same date last year. The number of transactions also rose sharply, increasing by 46.6%. The figures reflect activity from stores that were operating in both 2025 and 2026, a method the company used to avoid overstating growth due to newly opened locations. |
| Apr 30, 2026 |
Canadian Cannabis Edibles Company Completes First Australian Export, Generating $350,000 in Revenue
The global medical cannabis market is in a genuine expansion phase, with Australia emerging as an active and fast-growing market outside of North America. Since the country's regulatory framework matured in recent years, patient numbers and product diversity have increased significantly. Edibles, in particular, are attracting attention due to their precise dosing, longer shelf life, and familiar consumer format. The ability to export compliant, GMP-certified products from Canada into this international channel is becoming a meaningful competitive advantage. |
| Apr 30, 2026 |
BC cannabis sales level off as direct delivery sales continue to soar in Q4 2025
BC wholesaled $142.9 million worth of cannabis in the first three months of 2026 (Q4 FY 2025) while the overall price of cannabis in the province has continued to decline. Sales in the most recent quarter were relatively level year-over-year, down just under 1% compared to the same quarter in the previous year. This amounted to about 37,966 kilograms of cannabis. The overall price of cannabis per gram in BC in the most recent quarter was $3.76 per gram, while dried flower was $3.14 per gram. The number of retail stores in the province grew 3% YOY, up from 513 in Q4 FY2024 to 528 in Q4 FY2025. |
| Apr 30, 2026 |
Senate Committee on Indigenous Peoples examines responses on Cannabis Act
The standing Senate Committee on Indigenous Peoples examined responses of the 12th report by the federal government on the implementation of the Cannabis Act. |
| Apr 30, 2026 |
Cannabis homes: the future of construction?
Thousands of homes are being built using plant-based materials that experts say would help reduce carbon emissions in the construction industry. Hemp was once a staple crop until it was made illegal in the 1920s because of its psychoactive cousin - cannabis. The woody core of the hemp's stem can be processed into a solid, fireproof and breathable building material. |
| Apr 30, 2026 |
GOP-Led Congressional Committee Votes To Block Marijuana Rescheduling, Defying Trump
A key congressional panel has voted to block the federal rescheduling of marijuana—even though the Trump administration announced last week that it is moving ahead with enacting the reform. The House Appropriations Subcommittee on Commerce, Justice, Science, and Related Agencies on Thursday approved a funding bill containing a provision that, if enacted, would prevent federal officials from taking further steps to carry out cannabis rescheduling. “SEC. 591. None of the funds appropriated under this Act or otherwise made available by this Act may be used to reschedule marijuana (as such term is defined in section 102 of the Controlled Substances Act (21 U.S.C. 802)) or to remove marijuana from the schedules established under section 202 of the Controlled Substances Act (21 U.S.C. 812).” |
| Apr 30, 2026 |
They Said Weed Would Destroy America. They Were Wrong. They’re Still Cashing In.
Key Takeaways Six years after Alex Berenson’s predictions of cannabis-driven crime and psychosis epidemics, the data show neither materialized. Being wrong has not ended his media career — subscriber-driven revenue models reward narrative consistency over factual accuracy. National violent crime data for 2024 show continued declines, including a 14.9% drop in murder. |
| Apr 30, 2026 |
Jamaica: Growers association welcomes US cannabis reclassification
The Ganja Growers and Producers Association of Jamaica (GGPAJ) has welcomed the recent reclassification of cannabis under United States (US) federal law from a Schedule I to a Schedule III substance, describing the development as a significant global shift with both opportunity and urgency for Jamaica's ganja industry. |
| Apr 30, 2026 |
How cannabis legalization reshaped illicit markets in the Western Balkans
Before 2016, North Macedonia acted primarily as an important transit hub for Albanian cannabis destined for countries such as Türkiye, Greece and Serbia. The introduction of legislation to legalize the drug for medical purposes, however, opened the door to illicit cultivation, and quietly transformed the existing trafficking geography. |
| Apr 29, 2026 |
Trucking Industry in Grey Area as Marijuana is Reclassified Federally
A directive signed by Acting AG Todd Blanche on April 22 and put into force the next day shifts two categories of cannabis from Schedule I of the CSA to Schedule III. One includes marijuana-based medications approved by the FDA. The other applies to cannabis produced, distributed, or sold under state-issued medical licenses. The second group carries particular relevance for trucking. It covers legally sanctioned dispensaries where drivers with valid medical authorization can purchase cannabis in most states. |
| Apr 29, 2026 |
Indiana spends $1.8 billion on illegal cannabis, renewing legalization debate
Residents of Indiana, one of the few remaining U.S. states with no legal cannabis access, spend an estimated $1.8 billion annually on the drug, according to a recent state-commissioned study. A quantification of that sizable appetite, coupled with federal marijuana rescheduling, could change Republican Gov. Mike Braun’s stance on cannabis legalization, he told reporters on Tuesday. |
| Apr 29, 2026 |
Multipacks are reshaping Canada’s cannabis edibles market
In less than a year, edibles sold in multipacks have gone from a niche format to a defining force, changing how consumers buy, how retailers stock, and how brands compete. What started as a regulatory adjustment has quickly become one of the most meaningful shifts the category has seen since legalization, say some familiar with the category. “Multipacks have grown from just 2% of category sales to 28% in under a year,” says Matt Wowk, Sales Director at Olli Brands. “That’s not just growth; that’s a fundamental shift in how consumers are shopping for edibles.” |
| Apr 29, 2026 |
There’s ‘Strong Public Demand’ For Bigger Marijuana Reform Than Trump’s Rescheduling Move, Federally Funded Study Shows
The Trump administration’s move to reschedule marijuana is popular, but most people support even broader cannabis reforms, according to a new federally funded study that examines public comments received during the government’s official consideration of the proposal. |
| Apr 29, 2026 |
Industry Publishes New Guidance for Patients Travelling with Medical Cannabis
The Cannabis Industry Council has published a new patient-focused guide, Travelling with Medical Cannabis, offering practical advice for UK patients navigating the complex and often inconsistent rules around travelling with prescribed medical cannabis. |
| Apr 29, 2026 |
World’s Oldest Cannabis Plant May Have Been Found in a Berlin Museum — and It’s 56 Million Years Old
A fossilized leaf imprint found near Eisleben, Germany, may be 56 million years old, doubling the previously accepted timeline for the Cannabis genus and raising new questions about where the plant actually came from. Researchers say further investigation is underway. The implications are enormous either way. |
| Apr 28, 2026 |
Two Laws, One Plant
On April 23, 2026, the United States federal government did two things that do not belong in the same sentence. The Department of Justice, acting under a December 2025 executive order from President Donald Trump, issued a final order rescheduling FDA-approved marijuana products and state-licensed medical marijuana from Schedule I to Schedule III of the Controlled Substances Act. It was the most significant shift in federal drug policy in more than 50 years. Hours later, on the same day, the same president posted to Truth, urging Congress to act quickly to preserve Americans’ access to full-spectrum CBD products. |